Biotechnology innovations are revolutionizing healthcare with AI, data science, and automation, leading to more precise and ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Synthetic biology, an interdisciplinary and transformative field combining biology and engineering, is revolutionizing healthcare, agriculture, and energy. As the world enters this era of "synthetic ...

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

Charles River Laboratories on Wednesday beat fourth-quarter profit and revenue estimates, helped by stable demand for its drug discovery and development services from biotech clients.

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...